Why the study?
The burden of cardiovascular disease on breast cancer survivors compared to the general population and its temporal pattern remain uncertain.
Breast cancer survivors face an increased risk of cardiovascular death that emerges approximately seven years post-diagnosis, highlighting a critical window for risk factor modification.
May warrant long-term CVD monitoring in survivors; hypothesis-generating and needs prospective trials before practice change.
Breast cancer survivors are becoming increasingly concerned about cardiovascular disease (CVD). However, it is still uncertain how much of a burden this comorbidity has on this group compared to the overall population and its temporal pattern. Compared to women without breast cancer, breast cancer survivors are more likely to die from CVDs, and this increased risk becomes apparent about seven years after diagnosis. To lessen the excessive burden of CVD in this vulnerable population, efforts should be made to discover risk factors and therapies that can be used in this limited time frame.
No takes yet. Share an insight, caveat, or question.
Katoch et al. (2023) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: